1. A Randomized Phase III Trial of Busulfan + Melphalan Vs Melphalan Alone for Multiple Myeloma 
Muzaffar H. Qazilbash, MD, Peter Thall, PhD, Patricia S. Fox, MS, Partow Kebriaei, MD, Qaiser Bashir, MD, Nina Shah, MD, Krina Patel, MD, Borje S. Andersson, MD, PhD, Yago L. Nieto, MD, PhD, Ben C. Valdez, PhD, Simrit Parmar, MD, Gabriela Rondon, MD, Ruby Delgado, Yvonne Dinh, BS, Chitra Hosing, MD, Uday R. Popat, MD, Pei Lin, MD, Jatin Shah, Robert Z. Orlowski, MD, Richard E. Champlin, MD 
Biology of Blood and Marrow Transplantation 
Volume 21, Issue 2, Pages S87-S88 (February 2015)
DOI: /j.bbmt
Copyright © Terms and Conditions

2. Figure 1 PFS from Day 90 by Treatment Arm.
Biology of Blood and Marrow Transplantation  , S87-S88DOI: ( /j.bbmt )
Copyright © Terms and Conditions